Search Results - "Trinidad, Lyka"

High rates of tenofovir failure in a CRF01_AE-predominant HIV epidemic in the Philippines by Salvana, Edsel Maurice T., Samonte, Genesis May J., Telan, Elizabeth, Leyritana, Katerina, Tactacan-Abrenica, Rosario Jessica, Ching, Patrick R., Arevalo, Geraldine M., Dungca, Niña Theresa, Peñalosa-Ramos, Christine, Mendoza, Kevin Anthony R., Trinidad, Lyka F., Tonga, Angelo dela, Lim, Jodor, Destura, Raul, Alejandria, Marissa, Solante, Rontgene, Arcangel, Lalaine, Palaypayon, Noel S., Schwem, Brian E.

“…• Our study is the first systematic acquired drug resistance surveillance of HIV patients from the Philippines, which currently has one of the fastest growing…”
Get full text

HIV Treatment Failure and Acquired Drug Resistance After 1 Year on Antiretrovirals in the Philippines by Salvana, Edsel Maurice, Schwem, Brian, Samonte, Genesis, Tactacan-Abrenica, Rosario, Telan, Elizabeth, Mendoza, Kevin, Arevalo, Geraldine, Alejandria, Marissa, Leyritana, Katerina, Trinidad, Lyka, Lim, Jodor

Get full text

Together We Can Get There: Participatory Assessment of the Needs of Young M/TSM in Quezon City, Philippines by Samonte, Genesis May J., Mirano, Jessica Raphaela G., Tiu, John Edgar S., Montevirgen, Natasha Denise S., Trinidad, Lyka Eunice F., Baldonado, Aiza F., Caparida, Jay Arian, Palaypayon, Noel S., Cruz, Rolando V., Linga, Verdades P., Asuncion, Irma L.

Get full text

2507. Transmitted and Acquired NNRTI Resistance in the Philippines: Are Newer Generation NNRTIs a Viable Option? by Theresa Dungca, Nina, Schwem, Brian, Arevalo, Geraldine, Francisco, Christian, Penalosa-Ramos, Christine, Ching, Patrick, Leyritana, Katerina, Destura, Raul, Lim, Jodor, Tactacan-Abrenica, Rosario, Telan, Elizabeth, Solante, Rontgene, Samonte, Genesis, Trinidad, Lyka, Mendoza, Kevin, Alejandria, Marissa M, Salvana, Edsel Maurice T

“…Abstract Background Doravirine, rilpivirine, and etravirine are newer generation non-nucleoside reverse transcriptase inhibitors (NNRTI) that are intended to…”
Get full text

High Tenofovir Failure Rates in an Emerging, Non-B Subtype HIV Epidemic by Salvana, Edsel Maurice, Schwem, Brian, Samonte, Genesis, Telan, Elizabeth, Tactacan-Abrenica, Rosario, Ching, Patrick, Mendoza, Kevin, Arevalo, Geraldine, Alejandria, Marissa, Leyritana, Katerina, Trinidad, Lyka, Penalosa, Christine, Lim, Jodor

“…Abstract Background The WHO-recommended regimen for antiretrovirals (ARVs) is tenofovir (TDF) + lamivudine/emtricitabine (3TC/FTC) + efavirenz (EFV), based on…”
Get full text